Research and regulatory collaboration between Canadian biotechs Red Light Holland (OTCQB:TRUFF) and PharmAla (OTC:MDXXF) is bearing fruit. The partners are moving forward with a new project to bring Active Pharmaceutical Ingredient (API) extraction from Red Light’s psilocybin truffles to a commercial manufacturing scale.
An Ontario-based company producing, growing and selling functional mushrooms and mushroom home-grow kits in North America and Europe and premium psilocybin truffles in the Netherlands, Red Light Holland (RLH) recently hired MDXX-class molecules developer PharmAla for a one-year collaboration to seek regulatory approval ...